| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC1693 |
| Trial ID | NCT03049449 |
| Disease | Diffuse Large B-Cell Lymphoma | Nasal Type Extranodal NK/T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Anaplastic Large Cell Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas |
| Year | 2017 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 170048|17-C-0048 |
| Cohort 1 | |||||||||||||
|
|||||||||||||